Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Noradrenaline metabolism in the venous wall involves the breakdown of noradrenaline by MAO and COMT, as well as its interaction with alpha and beta adrenergic receptors. This process regulates venous smooth muscle tone, influencing venous return and blood pressure. The primary effect is venoconstriction mediated by alpha-adrenoceptors. Clinically, noradrenaline is used to treat hypotension and shock, but its use carries risks such as tissue necrosis and hypertension.
N/A
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Noradrenaline Metabolism (Venous Wall) (N/A).